Urelumab(BMS-66513) is a humanized IgG4 monoclonal antibody, often used as a CD137 agonist.Urelumab has potential antitumor activity, potentiating tumor cell killing by T-cells and natural killer cells, and enhancing the cytotoxicity of Rituximab.Ureluma
CAS Number:
[934823-49-1]
Target:
BMS-66513 , BMS-663513
* VAT and and shipping costs not included. Errors and price changes excepted